Sarepta Duchenne gene therapy wins broader use from FDA
| By Sequoia Administrator | 0 Comments
Category: News
The Dangers, Cost of Weight Loss Drugs and How to Avoid a “Life Sentence” of Dependency On Them
| By Sequoia Administrator | 0 Comments
Bristol Myers secures another FDA go-ahead for Breyanzi, this time in mantle cell lymphoma
| By Sequoia Administrator | 0 Comments
BMS CAR-T Therapy Wins FDA Approval for Expanded Use in Follicular Lymphoma
| By Sequoia Administrator | 0 Comments
Pfizer will charge $3.5M for its first FDA- approved gene therapy
| By Sequoia Administrator | 0 Comments
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment
| By Sequoia Administrator | 0 Comments
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
| By Sequoia Administrator | 0 Comments
U.S. FDA Approves Bristol Myers Squibb’s Breyanzi ® as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
| By Sequoia Administrator | 0 Comments
US FDA grants accelerated approval for Iovance’s skin cancer therapy
| By Sequoia Administrator | 0 Comments
Vertex, CRISPR’s gene-editing therapy Casgevy wins early FDA nod to treat beta thalassemia
| By Sequoia Administrator | 0 Comments
Recent Comments